{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T16:47:33Z","timestamp":1760978853529},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1245\/aso.2003.03.055","type":"journal-article","created":{"date-parts":[[2003,5,6]],"date-time":"2003-05-06T23:27:31Z","timestamp":1052263651000},"page":"408-415","source":"Crossref","is-referenced-by-count":74,"title":["Sentinel Lymph Node Mapping for Thick (?4-mm) Melanoma: Should We Be Doing It?"],"prefix":"10.1245","volume":"10","author":[{"given":"Grant W.","family":"Carlson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas R.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Hestley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Staley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Lyles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622?34.","journal-title":"J Clin Oncol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0011-3840(94)90025-6","volume":"31","author":"PF Mansfield","year":"1994","unstructured":"Mansfield PF, Lee JE, Balch CM. Cutaneous melanoma: current practice and surgical controversies. Curr Probl Surg 1994;31:253?374.","journal-title":"Curr Probl Surg"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1072-7515(98)00296-8","volume":"188","author":"SH Kim","year":"1999","unstructured":"Kim SH, Garcia C, Rodriguez J, et al. Prognosis of thick cutaneous melanoma. J Am Coll Surg 1999;188:241?7.","journal-title":"J Am Coll Surg"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s10434-000-0160-4","volume":"7","author":"JE Gershenwald","year":"2000","unstructured":"Gershenwald JE, Mansfield PF, Lee JE, et al. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma. Ann Surg Oncol 2000;7:160?5.","journal-title":"Ann Surg Oncol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00000658-200102000-00015","volume":"233","author":"BM Clary","year":"2001","unstructured":"Clary BM, Brady MS, Lewis JJ, et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 2001;233:250?8.","journal-title":"Ann Surg"},{"issue":"(1 Suppl 4):","key":"CR6","first-page":"S8","volume":"24","author":"R Essner","year":"1997","unstructured":"Essner R. The role of lymphoscintigraphy and sentinel node mapping in assessing patient risk in melanoma. Semin Oncol 1997;24(1 Suppl 4):S8?10.","journal-title":"Semin Onco"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s002689900307","volume":"21","author":"R Pijpers","year":"1997","unstructured":"Pijpers R, Borgstein PJ, Meijer S, et al. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 1997;21:788?92; discussion 793.","journal-title":"World J Surg"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1177\/000313480006600816","volume":"66","author":"DR Murray","year":"2000","unstructured":"Murray DR, Carlson GW, Greenlee R, et al. Surgical management of malignant melanoma using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy: the Emory experience. Am Surg 2000;66:763?7.","journal-title":"Am Surg"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archsurg.1990.01410150044009","volume":"125","author":"D Coit","year":"1990","unstructured":"Coit D, Sauven P, Brennan M. Prognosis of thick cutaneous melanoma of the trunk and extremity. Arch Surg 1990;125:322?6.","journal-title":"Arch Surg"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF02303495","volume":"5","author":"KM Heaton","year":"1998","unstructured":"Heaton KM, Sussman JJ, Gershenwald JE, et al. Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma. Ann Surg Oncol 1998;5:322?8.","journal-title":"Ann Surg Oncol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/archsurg.1987.01400180089017","volume":"122","author":"S Schneebaum","year":"1987","unstructured":"Schneebaum S, Briele HA, Walker MJ, et al. Cutaneous thick melanoma. Prognosis and treatment. Arch Surg 1987;122:707?11.","journal-title":"Arch Surg"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10434-000-0469-z","volume":"7","author":"N Cascinelli","year":"2000","unstructured":"Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000;7:469?74.","journal-title":"Ann Surg Oncol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/cncr.10326","volume":"94","author":"E Zettersten","year":"2002","unstructured":"Zettersten E, Sagebiel RW, Miller JR, et al. Prognostic factors in patients with thick melanoma (> 4 mm). Cancer 2002;94:1049?56.","journal-title":"Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/BF02574479","volume":"9","author":"CR Ferrone","year":"2002","unstructured":"Ferrone CR, Panageas KS, Busam K, et al. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol 2002;9:637?45.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/ASO.2003.03.055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/ASO.2003.03.055\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/ASO.2003.03.055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T07:51:16Z","timestamp":1682495476000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/ASO.2003.03.055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1245\/aso.2003.03.055","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}